Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pipeline Therapeutics
Biotech
Contineum lowers expectations for $110M IPO
Contineum Therapeutics has lowered its IPO expectations as the J&J-partnered biotech prepares to make the jump to the public markets this morning.
James Waldron
Apr 5, 2024 7:00am
J&J-allied bio files IPO to take fight to BMS, Roche and more
Mar 18, 2024 7:15am
Identifying 'gems': J&J gives insider look at dealmaking spree
May 15, 2023 5:00am
J&J opens the valve on $50M MS partnership with Pipeline
Apr 17, 2023 8:00am
Pipeline banks $80M to propel hearing loss, MS programs
Feb 11, 2021 8:00am
